Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] LigaChem Biosciences (141080) – Kyobo Securities | Pipeline Clinical Progress · IND Filings · Tech Transfer / 2026-04-01 Research
  • [Research] Samsung SDI (006400/KS) – SK Securities | Prominent Base Effects · Conservative CapEx Management · Compelling Valuation / 2026-02-03 Research
  • [IR] Samsung Electronics (005930) – Q2 2026 Earnings Presentation / 2026-07-30 IR Room
  • [Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Surprise · Cost & Incentive Factors · Earnings Volatility / 2026-07-28 Research
  • [Research] ABL Bio (298380) – Shinhan Securities | Sanofi Strategy · Clinical Differentiation · Platform Expansion / 2026-02-02 Research
  • [Research] Samsung Biologics (207940) – IBK Securities | Plant 5 PPQ Revenue · US Site Consolidation · Guidance Revision Potential / 2026-04-23 Research
  • [Research] Samsung SDI (006400) – IBK Securities | Fully Booked North America ESS Expected · European IAA Benefits · 1Q Earnings Resilience / 2026-04-02 Research
  • [IR] Samsung Electronics (005930) – Q2 2025 Earnings Presentation / 2025-07-31 IR Room

[Research] SK hynix (000660 / SKHY) – Mirae Asset | Multi-Year LTA · Price Downside Protection · ROE Sustainability / 2026-04-06

Posted on April 6, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Mirae Asset Securities

Analyst : Younggun Kim

Investment Rating : BUY (Maintained)

Target Price : 1,540,000 KRW (Maintained)

Core Momentum : Expanding multi-year LTAs with big-tech customers are expected to provide downside protection for memory pricing and reduce oversupply risk, supporting sustained high margins and structurally elevated ROE despite macro and consumer-demand uncertainties.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price / Investment Rating: 1,540,000 KRW / BUY (Maintain)
  • Current Price (as of 26/4/3): 876,000 KRW (Upside potential: 75.8%)
  • Market Capitalization: 624,327 billion KRW (Free float ratio: 75.2%)
  • Key Financial Metrics (2024 / 2025 / 2026F / 2027F / 2028F):
    • Revenue: 66,193 billion KRW / 97,147 billion KRW / 324,319 billion KRW / 439,423 billion KRW / 498,732 billion KRW
    • Operating Profit: 23,467 billion KRW / 47,206 billion KRW / 254,404 billion KRW / 346,929 billion KRW / 384,524 billion KRW
    • Operating Profit Margin: 35.5% / 48.6% / 78.4% / 79.0% / 77.1%
    • Net Income: 19,789 billion KRW / 42,919 billion KRW / 189,005 billion KRW / 264,968 billion KRW / 302,632 billion KRW
    • EPS: 27,182 KRW / 58,955 KRW / 264,580 KRW / 371,779 KRW / 424,627 KRW
    • P/E: 6.4x / 11.0x / 3.3x / 2.4x / 2.1x
    • P/B: 1.7x / 3.9x / 2.0x / 1.1x / 0.7x
    • ROE: 31.1% / 44.2% / 88.3% / 60.4% / 42.1%

🚀 2. [Market Opportunities & Business Outlook]

  • 1Q26 Earnings Outlook: 1Q26F performance is estimated at revenue of 53.5 trillion KRW (+63.0% QoQ) and operating profit of 38.9 trillion KRW (+103.1% QoQ), outperforming market consensus (OP 35.6 trillion KRW). DRAM and NAND ASP growth rates are estimated at +60.8% and +55.3% respectively, while lower cost (Cash cost) burden estimates have lifted OPMs to 78.7% and 55.4%.
  • Mid-to-Long-Term Earnings Growth & Shareholder Returns: Earnings expansion is expected to continue, with 2Q26 operating profit projected at 61.9 trillion KRW and full-year 2026 operating profit at 254.4 trillion KRW (YoY +439%). Backed by strong profit generation capacity, possibilities are raised for utilizing funds raised via ADR issuance for domestic share buybacks and cancellations, acting as a multiplier effect for re-rating in a high-valuation market friendly to shareholder returns.
  • Significance of Long-Term Agreements (LTAs): LTAs spanning 3 years or more are being established between memory makers and big tech clients, with clients prioritizing volume security over price negotiations. Customers pay a certain ratio of prepayments and undergo quarterly price re-negotiations to align prepayment collateral ratios. As the proportion of long-term contract clients expands, targets for market share competition diminish for sellers, alleviating oversupply concerns.
  • Profitability Sustainability: Despite slowing consumer set demand and big tech FCF burdens, maintaining LTA pricing levels alone will enable sustainable ROE of around 60%, serving as a catalyst for P/B band upward re-ratings.

📝 Editor’s Comment (Perspective)

The analyst evaluates that despite macro uncertainties and memory spot price corrections, SK hynix has entered a phase of securing price downside rigidity through the expansion of 3+ year long-term supply agreements (LTAs), maintaining stable high margins supported by high earnings visibility and an ROE around 60%. This perspective places greater emphasis on structural long-term contracts and fundamental earning power rather than short-term market fluctuations.

To determine whether this investment thesis is unfolding as projected, key items to monitor include the delivery of the projected 38.9 trillion KRW operating profit for Q1, the expansion and maintenance of 3+ year LTAs with big tech clients along with prepayment and price re-negotiation structures, and the execution of shareholder return policies such as share buybacks and cancellations utilizing ADR proceeds. These developments can be tracked through upcoming quarterly and annual earnings releases, official corporate IR materials, and regulatory disclosures via DART/KRX.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] SK hynix (000660 / SKHY) – Shinhan | Memory Pricing · LTA · Supplier Pricing Power / 2026-04-06
Next Post: [Research] ABL Bio (298380) – DS Investment & Securities | ABL001 Data Readout · ABL111 Phase 3 · Grabody B Expansion / 2026-04-07

Related Posts

  • [Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | ADR Listing · PHLX Inclusion · Valuation Re-rating / 2026-06-01 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | AI Infrastructure · LTA · HBM Demand / 2026-06-09 Research
  • [Research] Alteogen (196170) – Shinhan Securities | First UK Patent Ruling Favors Merck · Positive Read-across to Global Disputes · Pipeline Out-Licensing Ahead / 2026-02-23 Research
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Server Memory Demand · HBM3E Pricing · Margin Expansion / 2026-01-30 Research
  • [Research] Samsung Biologics (207940) – Kiwoom Securities | Plant 6 Groundbreaking Visibility · Labor Negotiation · Rockville Revenue Recognition / 2026-04-02 Research
  • [Research] LIG D&A (079550) – Hanwha Investment & Securities | 3Q25 Review · Secured Growth Materialization · Expanding Export Share / 2025-11-07 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | BBU Momentum · Hungarian Utilization Rebound · 2026 Operating Profit Turnaround / 2026-03-18 Research
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | MLCC Price Cycle · Customer Prepayments · Server Demand / 2026-08-11 Research
  • [Research] Samsung SDI (006400) – Hana Securities | Stepwise Loss Reduction · Strong ESS BBU Shipments · 4Q26 Turnaround / 2026-02-03 Research
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Commodity DRAM · ASP Resilience · Earnings Growth / 2026-07-29 Research
  • [IR] Samsung Electronics (005930) – Q1 2024 Earnings Presentation / 2024-04-30 IR Room
  • [IR] Samsung Electronics (005930) – Q3 2024 Earnings Presentation / 2024-10-31 IR Room
  • [Research] SK hynix (000660 / SKHY) – iM Securities | DRAM Pricing · ADR Listing · Multiple Recovery / 2026-04-24 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme